pmc logo image
Logo of westjmedJournal URL: http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=183&action=archive
Journal List > West J Med > v.138(1); Jan 1983

Formats:
West J Med. 1983 January; 138(1): 43–46.
PMCID: PMC1010626
Copyright notice
Colchicine Use for Familial Mediterranean Fever—Observations Associated With Long-term Treatment
Robert S. Peters, MD, Thomas J. A. Lehman, MD, and Arthur D. Schwabe, MD
Abstract
Of 85 patients with familial Mediterranean fever receiving continuous prophylactic colchicine therapy, 62 (73 percent) have had a significant reduction in the severity and frequency of their attacks. All 62 have been observed for three years or more, for a total of 4,680 patient-months and a mean duration of 75.5 months. Of the 85 patients, 23 (27 percent) did not complete three years of treatment for a variety of reasons. Diarrhea was the most common side effect, necessitating reduction of colchicine dosage in 12 patients, but discontinuation of treatment in only one. No other significant side effects were observed. Continuous, prophylactic colchicine therapy is effective in preventing the recurrent febrile paroxysms of familial Mediterranean fever and is indicated in those patients who are incapacitated by frequent attacks or who are at risk for amyloidosis developing.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (711K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 43
43
icon of scanned page 44
44
icon of scanned page 45
45
icon of scanned page 46
46
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med. 1974 Oct 31;291(18):932–934. [PubMed]
  • Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med. 1974 Oct 31;291(18):934–937. [PubMed]
  • Goldstein RC, Schwabe AD. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study. Ann Intern Med. 1974 Dec;81(6):792–794. [PubMed]
  • Familial Mediterranean fever. Recent advances in pathogenesis and management. West J Med. 1977 Jul;127(1):15–23. [PubMed]
  • Levy M, Eliakim M. Long-term colchicine prophylaxis in familial Mediterranean fever. Br Med J. 1977 Sep 24;2(6090):808–808. [PubMed]
  • Bakir F. Periodic peritonitis. Present management and future prospects. Arch Intern Med. 1979 Jul;139(7):781–783. [PubMed]
  • HELLER H, SOHAR E, SHERF L. Familial Mediterranean fever. AMA Arch Intern Med. 1958 Jul;102(1):50–71. [PubMed]
  • Race TF, Paes IC, Faloon WW. Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents. Am J Med Sci. 1970 Jan;259(1):32–41. [PubMed]
  • Webb DI, Chodos RB, Mahar CQ, Faloon WW. Mechanism of vitamin B12 malabsorption in patients receiving colchicine. N Engl J Med. 1968 Oct 17;279(16):845–850. [PubMed]
  • CARR AA. COLCHICINE TOXICITY. Arch Intern Med. 1965 Jan;115:29–33. [PubMed]
  • Stemmermann GN, Hayashi T. Colchicine intoxication. A reappraisal of its pathology based on a study of three fatal cases. Hum Pathol. 1971 Jun;2(2):321–332. [PubMed]
  • Liu YK, Hymowitz R, Carroll MG. Marrow aplasia induced by colchicine. A case report. Arthritis Rheum. 1978 Jul–Aug;21(6):731–735. [PubMed]
  • Stapczynski JS, Rothstein RJ, Gaye WA, Niemann JT. Colchicine overdose: report of two cases and review of the literature. Ann Emerg Med. 1981 Jul;10(7):364–369. [PubMed]
  • Zemer D, Pras M, Sohar E, Gafni J. Letter: Colchicine in familial Mediterranean fever. N Engl J Med. 1976 Jan 15;294(3):170–171. [PubMed]
  • Wright DG, Wolff SM, Fauci AS, Alling DW. Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med. 1977 Feb;86(2):162–165. [PubMed]
  • Ravid M, Robson M, Kedar I. Prolonged colchicine treatment in four patients with amyloidosis. Ann Intern Med. 1977 Nov;87(5):568–570. [PubMed]
  • Rudolph SA, Greengard P, Malawista SE. Effects of colchicine on cyclic AMP levels in human leukocytes. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3404–3408. [PubMed]
  • Greene WC, Parker CM, Parker CW. Colchicine-sensitive structures and lymphocyte activation. J Immunol. 1976 Sep;117(3):1015–1022. [PubMed]
Articles from The Western Journal of Medicine are provided here courtesy of
BMJ Group

PubMed articles by these authors